Highlight
Steady Growth, 18% Net Income Increase.
Upholding its philosophy of sustainable management, ScinoPharm continued to expand its business and enhance its financial performance on the basis of stable operations, achieving a year-over-year increase of 18% in net income after tax in 2024.
18.3% Carbon Reduction, 2.4% Waste Reduction: Fulfilling Our Environmental Commitment.
Through effective improvement measures identified by the Greenhouse Gas (GHG) Inventory, the Company reduced its GHG emissions by 18.3% in 2024 compared to the previous year. Furthermore, the continuous optimization of waste reduction and management resulted in a 2.4% decrease from the previous year, demonstrating the Company's firm commitment to environmental protection.
ScinoPharm: Recognized with Three Major Sustainability Awards.
-
Awarded the 2025 "Excellence in Corporate Social Responsibility Award" issued by CommonWealth Magazine.
-
Awarded Business Weekly 2024 "Top 100 Carbon Competitiveness"
-
Awarded 21st Century Foundation "Net-Zero Industry Competitiveness" Excellence Award
